Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis
- PMID:15824745
- DOI: 10.1038/sj.mp.4001663
Population-based and family-based studies on the serotonin transporter gene polymorphisms and bipolar disorder: a systematic review and meta-analysis
Abstract
The serotonin transporter (5-HTT) is a candidate gene for bipolar disorder (BPD). It has been investigated for association with the illness in a series of studies, but overall results have been inconsistent and its role in the disorder remains controversial. Systematic reviews using meta-analytical techniques are a useful method for objectively and reproducibly assessing individual studies and generating combined results. We performed two meta-analyses of published studies--both population-based and family-based studies--investigating the association between BPD and the 5-HTT gene-linked polymorphic region (5-HTTLPR) and the intron 2 variable numbers of tandem repeats (VNTR) polymorphisms. The literature was searched using Medline and Embase to identify studies for inclusion. We statistically joined population-based and family-based studies into a single meta-analysis. For both polymorphisms, our review revealed significant pooled odds ratios (ORs): 1.12 (95% CI 1.03-1.21) for the 5-HTTLPR and 1.12 (95% CI 1.02-1.22) for the intron 2 VNTR. Meta-regression showed that neither the study type (population-based vs family-based; P=0.41 for the 5-HTTLPR and P=0.91 for the intron 2 VNTR) nor the sample ethnicity (Caucasian vs non-Caucasian; P=0.35 for the 5-HTTLPR and P=0.66 for the intron 2 VNTR) significantly contributed to the heterogeneity of the meta-analyses. The observed ORs could be regarded simply as a very small but detectable effect of the 5-HTT, which has an additive effect when combined with other susceptibility loci. Alternative hypotheses on this finding were also discussed: a stronger effect of the haplotypes involving the two polymorphisms or other SNP markers; a more direct effect of these polymorphisms on specific phenotypes of BPD; and the presence of gene-environment interaction as a mediator of the genetic effects of 5-HTT.
Similar articles
- A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders.Anguelova M, Benkelfat C, Turecki G.Anguelova M, et al.Mol Psychiatry. 2003 Jun;8(6):574-91. doi: 10.1038/sj.mp.4001328.Mol Psychiatry. 2003.PMID:12851635
- Autism and serotonin transporter gene polymorphisms: a systematic review and meta-analysis.Huang CH, Santangelo SL.Huang CH, et al.Am J Med Genet B Neuropsychiatr Genet. 2008 Sep 5;147B(6):903-13. doi: 10.1002/ajmg.b.30720.Am J Med Genet B Neuropsychiatr Genet. 2008.PMID:18286633
- Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM, Spijker R, Hooft L, Emperador D, Domen J, Tans A, Janssens S, Wickramasinghe D, Lannoy V, Horn SRA, Van den Bruel A; Cochrane COVID-19 Diagnostic Test Accuracy Group.Struyf T, et al.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.Cochrane Database Syst Rev. 2022.PMID:35593186Free PMC article.
- Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.MacLeod A, Daly C, Khan I, Vale L, Campbell M, Wallace S, Cody J, Donaldson C, Grant A.MacLeod A, et al.Cochrane Database Syst Rev. 2001;(3):CD003234. doi: 10.1002/14651858.CD003234.Cochrane Database Syst Rev. 2001.Update in:Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003234. doi: 10.1002/14651858.CD003234.pub2.PMID:11687058Updated.
- Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.McAleenan A, Jones HE, Kernohan A, Robinson T, Schmidt L, Dawson S, Kelly C, Spencer Leal E, Faulkner CL, Palmer A, Wragg C, Jefferies S, Brandner S, Vale L, Higgins JP, Kurian KM.McAleenan A, et al.Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.Cochrane Database Syst Rev. 2022.PMID:35233774Free PMC article.
Cited by
- Meta-analyses of the 5-HTTLPR polymorphisms and post-traumatic stress disorder.Navarro-Mateu F, Escámez T, Koenen KC, Alonso J, Sánchez-Meca J.Navarro-Mateu F, et al.PLoS One. 2013 Jun 25;8(6):e66227. doi: 10.1371/journal.pone.0066227. Print 2013.PLoS One. 2013.PMID:23825531Free PMC article.
- Serotonin transporter polymorphism is associated with increased apnea-hypopnea index in older adults.Schröder CM, Primeau MM, Hallmayer JF, Lazzeroni LC, Hubbard JT, O'Hara R.Schröder CM, et al.Int J Geriatr Psychiatry. 2014 Mar;29(3):227-35. doi: 10.1002/gps.3994. Epub 2013 Jun 11.Int J Geriatr Psychiatry. 2014.PMID:23754303Free PMC article.
- Association of Anxiety Symptoms in Offspring of Bipolar Parents with Serotonin Transporter-Linked Polymorphic Region (5-HTTLPR) Genotype.Park MH, Sanders E, Howe M, Singh M, Hallmayer J, Kim E, Chang K.Park MH, et al.J Child Adolesc Psychopharmacol. 2015 Aug;25(6):458-66. doi: 10.1089/cap.2014.0115. Epub 2015 Jul 28.J Child Adolesc Psychopharmacol. 2015.PMID:26218602Free PMC article.
- A review on shared clinical and molecular mechanisms between bipolar disorder and frontotemporal dementia.Nascimento C, Nunes VP, Diehl Rodriguez R, Takada L, Suemoto CK, Grinberg LT, Nitrini R, Lafer B.Nascimento C, et al.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jul 13;93:269-283. doi: 10.1016/j.pnpbp.2019.04.008. Epub 2019 Apr 20.Prog Neuropsychopharmacol Biol Psychiatry. 2019.PMID:31014945Free PMC article.Review.
- Association between Neurocognitive Impairment and the Short Allele of the 5-HTT Promoter Polymorphism in Depression: A Pilot Study.Kalska H, Pesonen U, Lehikoinen S, Stenberg JH, Lipsanen J, Niemi-Pynttäri J, Tuunainen A.Kalska H, et al.Psychiatry J. 2013;2013:849346. doi: 10.1155/2013/849346. Epub 2012 Dec 18.Psychiatry J. 2013.PMID:24286069Free PMC article.